Abdominal pain and hematochezia could be crucial red flags for early-onset colorectal cancer

FHS
May 29, 2024
3:57 am

The study identifies key symptoms like abdominal pain and hematochezia as significant indicators of early-onset colorectal cancer and stresses the importance of early diagnosis to improve survival rates.

Abivax announces the filing of an amended registration statement, including an estimated initial public offering price range – Biotech Investments

EQS-News: ABIVAX / Key word(s): IPO Abivax announces the filing of an amended registration statement, including an estimated initial public offering price range 19.10.2023 /

October 20, 2023

Placebos Linked to Potential Harms in IBD Clinical Trials

In successful clinical trials of drugs for inflammatory bowel disease (IBD), patients who received a placebo were at significantly higher risk for potential harms, according

September 27, 2024

Merck’s next big thing is (probably) on the way

New biotech newsletter launching this Thursday. Don’t miss out. Hello, everyone. Damian here with a look at a pivotal FDA approval, good news for a small

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.